4. Effect of intervention.
Outcome |
Farber 1991 (Randomised 174 eyes) Mean follow up of 42 to 47 months |
Jampol 1983 (Randomised 167 eyes) Mean follow up of 21 to 32 months |
|||
Laser (Argon Scatter) | Control | Laser (Feeder vessel) | Control | ||
1 | Complete regression of PSR Partial egression of PSR |
30/99 (30.2%) 51/99 (51.0%) |
17/75 (22.4%) 18/75 (23.7%) |
78/87 (89.6%) | Not reported |
2 | Development of new PSR | 34/99 (34.3%) | 31/75 (41.3%) | Not reported | |
3 | Visual loss | 3/99 (3.0%) | 9/75 (8.3%) | 1/87 (1.14%) | 4/80 (5.0 %) |
4 | Occurrence of vitreous haemorrhage | 12/99 (12.0%) | 19/75 (25.3%) | 3/87 (3.4%) | 22/80 (27.5%) |
5 | Adverse effect: Retinal tear | Not reported | |||
6 | Adverse effect: Retinal detachment | 3/99 (3.0%) | 8/75 (10.6%) | 5/87 (5.74%) | No event |
7 | Adverse effect: Choroidal neovascularization | Not reported | 41/87 (47.12%) | No event |
Unit of analysis is the eye.
PSR: proliferative sickle retinopathy.
Farber 1991: Mean follow up of 42 months for control group and 47 months for treatment group.
Jampol 1983: Mean follow up of 21 months for Chicago centre and 32 months for Kingston, Jamaica (overall participants).